Cantitate/Preț
Produs

Winning Capability: A Novel Histone Lysine Mono-Methyltransferase

Autor Aino Piekkola
en Limba Engleză Paperback – 7 aug 2015
Entrepreneurship awards have become an integrated part in the national innovation system. However, a common understanding of this phenomenon can be regarded as insufficient within the entrepreneurship literature. This study investigated whether the participation in an award, as well as the interaction with its mechanisms and procedures can improve the success of a new technology based firm (NTBF). The study constructs a capability framework for NTBFs where generic capabilities are identified. The construct is induced based on the existing literature base on resources and capabilities, on NTBFs, as well as on success factors in startups, and is complemented by inductive data from case studies and from an explorative survey. Overall, this research demonstrates that there exists an impact from the investigated entrepreneurial award program on its participant companies. In particular, the participation increases the likelihood of specific capability to be created or beneficially sustained within the founder's team. Building on this effect, the relevance of entrepreneurial awards to society is strengthened, which award organizations in turn may capitalize on.
Citește tot Restrânge

Preț: 52967 lei

Preț vechi: 57573 lei
-8% Nou

Puncte Express: 795

Preț estimativ în valută:
10140 10540$ 8407£

Carte tipărită la comandă

Livrare economică 08-22 februarie 25

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9783838105932
ISBN-10: 3838105931
Pagini: 224
Dimensiuni: 152 x 229 x 12 mm
Greutate: 0.3 kg
Editura: Sudwestdeutscher Verlag Fur Hochschulschrifte
Locul publicării:Germany

Notă biografică

Aino Piekkola holds a PhD in management from ETH Zurich, and anMSc in business administration from Turku School of Economics.During 2005¿2008, she was project manager at ETH Zurich for theVenture competition. Prior to that, she obtained industryexperience in the finance sector. Since 2009, Dr. Piekkola is amanager in a pharmaceutical company.